Sapience Investments LLC Raises Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Sapience Investments LLC boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 64.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 78,885 shares of the company’s stock after purchasing an additional 31,056 shares during the period. Acadia Healthcare comprises 1.8% of Sapience Investments LLC’s investment portfolio, making the stock its 12th biggest position. Sapience Investments LLC owned approximately 0.08% of Acadia Healthcare worth $3,128,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of ACHC. Lindbrook Capital LLC increased its stake in Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. grew its holdings in Acadia Healthcare by 69.4% during the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in Acadia Healthcare by 40.7% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock valued at $41,000 after buying an additional 301 shares during the last quarter. Signaturefd LLC grew its holdings in Acadia Healthcare by 460.6% during the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after buying an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp grew its holdings in Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after buying an additional 454 shares during the last quarter.

Acadia Healthcare Trading Up 2.0%

Shares of ACHC opened at $26.15 on Friday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $2.41 billion, a P/E ratio of 8.57, a price-to-earnings-growth ratio of 1.46 and a beta of 1.01. The stock’s fifty day simple moving average is $26.19 and its 200 day simple moving average is $35.66. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The business had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. During the same period last year, the company posted $0.84 EPS. The business’s quarterly revenue was up .3% on a year-over-year basis. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages have commented on ACHC. KeyCorp lowered their target price on Acadia Healthcare from $65.00 to $55.00 and set an “overweight” rating on the stock in a report on Wednesday. Guggenheim started coverage on Acadia Healthcare in a report on Wednesday, April 9th. They set a “buy” rating and a $36.00 price objective on the stock. Barclays decreased their price objective on Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating on the stock in a report on Wednesday. Bank of America decreased their price objective on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Finally, Royal Bank of Canada decreased their price objective on Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.